Ansar Karimian

5.8k total citations · 1 hit paper
38 papers, 2.4k citations indexed

About

Ansar Karimian is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ansar Karimian has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Ansar Karimian's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Ansar Karimian is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Ansar Karimian collaborates with scholars based in Iran, Vietnam and Spain. Ansar Karimian's co-authors include Bahman Yousefi, Yasin Ahmadi, Maryam Majidinia, Hadi Parsian, Sadra Samavarchi Tehrani, Mohammad Mirza‐Aghazadeh‐Attari, Mehdi Yousefi, Amin Safa, Ainaz Mihanfar and Khalil Azizian and has published in prestigious journals such as Journal of Biological Chemistry, Gene and Biochemical Pharmacology.

In The Last Decade

Ansar Karimian

38 papers receiving 2.4k citations

Hit Papers

Multiple functions of p21 in cell cycle, apoptosis and tr... 2016 2026 2019 2022 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ansar Karimian Iran 23 1.5k 563 466 222 169 38 2.4k
Nasser Samadi Iran 34 1.6k 1.1× 502 0.9× 412 0.9× 333 1.5× 247 1.5× 98 2.9k
Yingchun Zhao China 29 1.1k 0.8× 514 0.9× 356 0.8× 296 1.3× 272 1.6× 125 2.5k
Chunxiao Zhou United States 31 1.7k 1.1× 860 1.5× 625 1.3× 161 0.7× 187 1.1× 134 2.8k
Rezvan Najafi Iran 27 1.3k 0.9× 680 1.2× 540 1.2× 143 0.6× 209 1.2× 122 2.7k
Yingjie Xu China 26 1.7k 1.2× 395 0.7× 312 0.7× 218 1.0× 231 1.4× 92 2.8k
Mohsen Rashidi Iran 24 996 0.7× 488 0.9× 320 0.7× 174 0.8× 166 1.0× 96 1.9k
Jie Ma China 28 1.5k 1.0× 490 0.9× 420 0.9× 211 1.0× 246 1.5× 210 2.9k
Yu Zhu China 26 1.5k 1.0× 683 1.2× 222 0.5× 222 1.0× 210 1.2× 91 2.3k
Qiwei Jiang China 27 1.1k 0.8× 389 0.7× 421 0.9× 155 0.7× 132 0.8× 61 1.9k
Liqun Chen China 28 1.4k 1.0× 544 1.0× 488 1.0× 131 0.6× 232 1.4× 69 2.7k

Countries citing papers authored by Ansar Karimian

Since Specialization
Citations

This map shows the geographic impact of Ansar Karimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansar Karimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansar Karimian more than expected).

Fields of papers citing papers by Ansar Karimian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansar Karimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansar Karimian. The network helps show where Ansar Karimian may publish in the future.

Co-authorship network of co-authors of Ansar Karimian

This figure shows the co-authorship network connecting the top 25 collaborators of Ansar Karimian. A scholar is included among the top collaborators of Ansar Karimian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ansar Karimian. Ansar Karimian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogelauer, Maria, et al.. (2024). The role of histone H3 leucine 126 in fine-tuning the copper reductase activity of nucleosomes. Journal of Biological Chemistry. 300(6). 107314–107314. 2 indexed citations
2.
Karimian, Ansar, et al.. (2023). Natural products and the balancing act of autophagy-dependent/independent ferroptosis in cancer therapy. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 2531–2549. 5 indexed citations
4.
Malakoti, Faezeh, Forough Alemi, Maryam Majidinia, et al.. (2021). The cross-talk between signaling pathways, noncoding RNAs and DNA damage response: Emerging players in cancer progression. DNA repair. 98. 103036–103036. 13 indexed citations
5.
Sadoughi, Fatemeh, et al.. (2021). The molecular mechanism of nuclear signaling for degradation of cytoplasmic DNA: Importance in DNA damage response and cancer. DNA repair. 103. 103115–103115. 3 indexed citations
6.
Karimian, Ansar, et al.. (2021). Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin. Chemico-Biological Interactions. 351. 109731–109731. 15 indexed citations
7.
Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2020). Critical roles of long noncoding RNAs in breast cancer. Journal of Cellular Physiology. 235(6). 5059–5071. 45 indexed citations
8.
Mirza‐Aghazadeh‐Attari, Mohammad, María J. Recio, Saber Ghazizadeh Darband, et al.. (2020). DNA damage response and breast cancer development: Possible therapeutic applications of ATR, ATM, PARP, BRCA1 inhibition. DNA repair. 98. 103032–103032. 15 indexed citations
9.
Majidinia, Maryam, Zatollah Asemi, Forough Alemi, et al.. (2020). Modulation of telomerase expression and function by miRNAs: Anti-cancer potential. Life Sciences. 259. 118387–118387. 16 indexed citations
10.
Karimian, Ansar, Hadi Parsian, Maryam Majidinia, et al.. (2019). RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. Journal of Cellular Physiology. 234(9). 14951–14965. 248 indexed citations
11.
Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2019). MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. Journal of Cellular Physiology. 235(6). 5008–5029. 75 indexed citations
12.
Karimian, Ansar, et al.. (2019). The roles of FGF21 in atherosclerosis pathogenesis. Reviews in Endocrine and Metabolic Disorders. 20(1). 103–114. 36 indexed citations
13.
Majidinia, Maryam, Ansar Karimian, Forough Alemi, Bahman Yousefi, & Amin Safa. (2019). Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging. Biochemical Pharmacology. 173. 113688–113688. 30 indexed citations
14.
Mahmoodpoor, Ata, et al.. (2019). Red Cell Distribution Width as a Novel Prognostic Marker in Multiple Clinical Studies. Indian Journal of Critical Care Medicine. 24(1). 49–54. 22 indexed citations
15.
Ahmadi, Yasin, et al.. (2019). The effects of statins with a high hepatoselectivity rank on the extra-hepatic tissues; New functions for statins. Pharmacological Research. 152. 104621–104621. 7 indexed citations
16.
Jahanban‐Esfahlan, Rana, Khaled Seidi, Maryam Majidinia, et al.. (2019). Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology. 29(4). e2048–e2048. 26 indexed citations
17.
Karimian, Ansar, Hadi Parsian, Maryam Majidinia, et al.. (2019). Nanocrystalline cellulose: Preparation, physicochemical properties, and applications in drug delivery systems. International Journal of Biological Macromolecules. 133. 850–859. 92 indexed citations
18.
Mirza‐Aghazadeh‐Attari, Mohammad, et al.. (2018). 53BP1: A key player of DNA damage response with critical functions in cancer. DNA repair. 73. 110–119. 97 indexed citations
20.
Majidinia, Maryam, Vahid Shafiei‐Irannejad, Rana Jahanban‐Esfahlan, et al.. (2017). Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. Gene. 642. 249–255. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026